Diclofenac sodium injection, specifically the 75 mg/ml formulation, is often packaged in a tray pack. This packaging typically includes 10 ampoules of 1 ml each. You can find examples of this packaging under names like “Plicadiclo AQ,” “FEDIMAC-75,” and “Dynapar AQ,” among others.

INTRODUCTION ABOUT CEFROCK T 280.25MG INJECTION CEFROCK T 280.25MG INJECTION is a combination of Ceftriaxone and Tazobactam which belongs to the group of medicines called Antibiotics. It is used to manage several bacterial infections like lower respiratory tract infections such as pneumonia, acute bacterial otitis media lower respiratory tract infections, pneumonia, infection in the ear, skin, urinary tract infections, gonorrhoea, pelvic inflammatory disease, bacterial septicaemia, bone and joint infections, intra-abdominal infections, including peritonitis and biliary tract infections, bacterial meningitis, surgical prophylaxis (pre-operative antibiotics, infections in neutropenic patients). Pneumonia is an infection which causes inflammation in the air sac producing cough with phlegm and shortness of breath. Urinary tract infection affects the urinary bladder later gets spreads to the kidneys. Bacteraemia is an infectious condition indicating presence of bacteria in the blood stream. Bacterial meningitis is an infection caused by bacteria in the region surrounding the brain. Neutropenic is low levels of neutrophils (a type of white blood cells) in our body. Inform your doctor or your health- care professional before any laboratory tests as CEFROCK T 280.25MG INJECTION will interact with medical investigations. Inform your doctor if you are allergic to any antibiotics or to any other medicines. CEFROCK T 280.25MG INJECTION should not be used in patients allergic to penicillin antibiotics, cefepime, tazobactam and other beta-lactam antibiotics. CEFROCK T 280.25MG INJECTION should be used with caution in patients with or history of allergic reactions, diarrhoea, gastrointestinal disease (colitis) kidney and liver diseases.

INTRODUCTION ABOUT CEFROCK T 1.125GM INJECTION CEFROCK T 1.125GM INJECTION is a combination of Ceftriaxone and Tazobactam which belongs to the group of medicines called Antibiotics. It is used to manage several bacterial infections like lower respiratory tract infections such as pneumonia, acute bacterial otitis media lower respiratory tract infections, pneumonia, infection in the ear, skin, urinary tract infections, gonorrhoea, pelvic inflammatory disease, bacterial septicaemia, bone and joint infections, intra-abdominal infections, including peritonitis and biliary tract infections, bacterial meningitis, surgical prophylaxis (pre-operative antibiotics, infections in neutropenic patients). Pneumonia is an infection which causes inflammation in the air sac producing cough with phlegm and shortness of breath. Urinary tract infection affects the urinary bladder later gets spreads to the kidneys. Bacteraemia is an infectious condition indicating presence of bacteria in the blood stream. Bacterial meningitis is an infection caused by bacteria in the region surrounding the brain. Neutropenic is low levels of neutrophils (a type of white blood cells) in our body. Inform your doctor or your health- care professional before any laboratory tests as CEFROCK T 1.125GM INJECTION will interact with medical investigations. Inform your doctor if you are allergic to any antibiotics or to any other medicines. CEFROCK T 1.125GM INJECTION should not be used in patients allergic to penicillin antibiotics, cefepime, tazobactam and other beta-lactam antibiotics. CEFROCK T 1.125GM INJECTION should be used with caution in patients with or history of allergic reactions, diarrhoea, gastrointestinal disease (colitis) kidney and liver diseases.

INTRODUCTION ABOUT CEFROCK S 375MG INJECTION CEFROCK S 375MG INJECTION is a combination of Ceftriaxone and Sulbactam, which belongs to the group of medicines called Antibiotics. It is used in the management of infections of the brain (meningitis), lungs, middle ear, abdomen, and abdominal wall (peritonitis), urinary tract and kidneys, bones and joints, skin or soft tissues, blood, and heart. CEFROCK S 375MG INJECTION can also be used to manage specific sexually transmitted infections (gonorrhoea and syphilis), patients with low white blood cell counts (neutropenia) who have fever due to bacterial infection, Lyme disease (caused by tick bites), and infections during surgery. CEFROCK S 375MG INJECTION is not recommended for use in premature babies and new-born babies having jaundice. Before receiving CEFROCK S 375MG INJECTION, inform your doctor if you have liver or kidney diseases, colitis, hemolytic anemia, gallstones or kidney stones, upcoming surgeries, or pancreatitis. CEFROCK S 375MG INJECTION should be used with caution in pregnancy and breast feeding. Contact your doctor before receiving. CEFROCK S 375MG INJECTION is not recommended for use in premature babies. Contact your child’s doctor. CEFROCK S 375MG INJECTION should be used with caution in elderly patients (aged above 65 years or above). Contact your doctor before receiving. The most common side effects of receiving CEFROCK S 375MG INJECTION are diarrhea, rash, itching, pain at the site of injection, and inflammation of a vein caused by blood clots. Contact your doctor if any of the symptoms worsen.

INTRODUCTION ABOUT CEFROCK S 375MG INJECTION CEFROCK S 375MG INJECTION is a combination of Ceftriaxone and Sulbactam, which belongs to the group of medicines called Antibiotics. It is used in the management of infections of the brain (meningitis), lungs, middle ear, abdomen, and abdominal wall (peritonitis), urinary tract and kidneys, bones and joints, skin or soft tissues, blood, and heart. CEFROCK S 375MG INJECTION can also be used to manage specific sexually transmitted infections (gonorrhoea and syphilis), patients with low white blood cell counts (neutropenia) who have fever due to bacterial infection, Lyme disease (caused by tick bites), and infections during surgery. CEFROCK S 375MG INJECTION is not recommended for use in premature babies and new-born babies having jaundice. Before receiving CEFROCK S 375MG INJECTION, inform your doctor if you have liver or kidney diseases, colitis, hemolytic anemia, gallstones or kidney stones, upcoming surgeries, or pancreatitis. CEFROCK S 375MG INJECTION should be used with caution in pregnancy and breast feeding. Contact your doctor before receiving. CEFROCK S 375MG INJECTION is not recommended for use in premature babies. Contact your child’s doctor. CEFROCK S 375MG INJECTION should be used with caution in elderly patients (aged above 65 years or above). Contact your doctor before receiving. The most common side effects of receiving CEFROCK S 375MG INJECTION are diarrhea, rash, itching, pain at the site of injection, and inflammation of a vein caused by blood clots. Contact your doctor if any of the symptoms worsen.

Ondansetron 2mg/ml in a tray pack is a common formulation used to prevent nausea and vomiting, particularly after chemotherapy or surgery. These injections are often packaged in trays containing multiple ampoules (e.g., 10 ampoules of 2ml each). The medication helps block signals to the brain that trigger nausea and vomiting.